Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 15,108 | 21,391 | 19,715 | 18,433 | -22,497 |
| Cost of Goods | 4,451 | 7,400 | 6,508 | 6,192 | -26,757 |
| Gross Profit | 10,657 | 13,991 | 13,207 | 12,241 | 4,260 |
| Operating Expenses | 10,566 | 14,809 | 15,021 | 15,728 | -19,000 |
| Operating Income | 542 | -418 | -1,306 | -3,295 | 22,503 |
| Other Income | -73 | -133 | -4,253 | 113 | 103 |
| Pre-tax Income | 469 | -551 | -5,559 | -3,182 | 22,606 |
| Income Tax | 24 | -80 | 1 | 17 | -269 |
| Net Income Continuous | 445 | -471 | -5,560 | -3,199 | 22,879 |
| Net Income Discontinuous | 12,014 | -1,232 | -15,159 | -7,022 | -37,836 |
| Net Income | $12,459 | $-1,703 | $-20,719 | $-10,221 | $-14,957 |
| EPS Basic Total Ops | 0.27 | -0.04 | -0.45 | -0.22 | -0.33 |
| EPS Basic Continuous Ops | 0.01 | -0.01 | -0.12 | -0.07 | 0.53 |
| EPS Basic Discontinuous Ops | 0.26 | -0.03 | -0.33 | -0.15 | -0.85 |
| EPS Diluted Total Ops | 0.27 | -0.04 | -0.45 | -0.22 | -0.33 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | -0.12 | -0.07 | 0.53 |
| EPS Diluted Discontinuous Ops | 0.26 | -0.03 | -0.33 | -0.15 | -0.85 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.02 | -0.06 | N/A | N/A |
| EBITDA(a) | $2,246 | $1,899 | $1,056 | $-1,017 | $24,886 |